Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Neostigmine metilsulfate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Neostigmine 2.5mg/1ml solution for injection ampoules
1002010N0AAABAB
|
Neostig metilsulf (parent) | Neostigmine metilsulfate | Musculoskeletal and Joint Diseases | No data available |
|
Neostigmine 2.5mg/Glycopyrronium brom 500microg/1ml inj amp
1501060N0AAAAAA
|
Neostigmine/ glycopyrronium bromide | Neostigmine metilsulfate | Anaesthesia | No data available |
|
Robinul-Neostigmine solution for injection 1ml ampoules
1501060N0BBAAAA
|
Robinul-Neostig | Neostigmine metilsulfate | Anaesthesia | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.